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Periodontal disease is a bacterial induced chronic inflammatory condition that occurs in a 
susceptible host, affecting the teeth, gingiva, periodontal ligament, and alveolar bone. The 
resultant pathological bone defects often require surgical intervention, with the ultimate goal 
being regeneration of the periodontium through the application of grafting materials and 
biologics. Mesenchymal stem cells (MSCs) show great potential in regenerative medicine for 
their ability to enhance cell proliferation and differentiation, increase angiogenesis, and modulate 
the immune response. Stem cell-derived by-products, known as exosomes are a specific class of 
lipid-membrane-bound extracellular vesicles that are proliferative and chemotactic, are able to 
inhibit cytokine production, and may suppress differentiation of osteoclasts. The aim of this 
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study is to determine if the delivery of exosomes into rat calvarial defects will increase 
regeneration by reducing the residual defect area and enhancing bone volume. Male Sprague-
Dawley rats with bilateral 5mm surgically-created calvarial defects were randomized into groups 
and treated with low- and high-dose  exosome suspensions via a collagen gel matrix or a PBS-
soaked collagen control. After 4 weeks, the calvaria were harvested and analyzed via micro 
computed tomography (micro-CT). Volumetric micro-CT analysis showed that defects treated 
with high-dose exosomes displayed a trend towards enhanced bone healing. Based on the results 
of this pilot study, treatment with exosomes could be a promising therapeutic approach for 
treatment of bone defects. 
 





Periodontal disease is a chronic inflammatory condition that is the result of a bacterial 
challenge in a susceptible host and affects the teeth, gingiva, periodontal ligament, and alveolar 
bone. According to a recent CDC report, 46% of adults over 30 in the U.S. have some form of 
periodontal disease.
1
 The aim of initial periodontal therapy is to reduce the bacterial load in the 
oral cavity through methods of scaling and root planning, however further surgical intervention 
is often necessary. The ultimate goal of periodontal treatment is the regeneration of the 
periodontium, which includes the alveolar bone, periodontal ligament, and cementum. Some 
clinical approaches to achieving regeneration of the periodontium include osseous grafting and 
guided tissue regeneration (“GTR”). These techniques use a variety of grafts, including 
autogenic, allogeneic, or xenogeneic bone and often combine them with other modalities such as 
membranes, and/or biologically active agents, such as enamel matrix derivate and growth-factor 
enhanced matrix containing platelet derived growth factor (rhPDGF-BB).
2,3
 In non-critically 
sized periodontal defects, regeneration occurring via the bodies’ own intramembranous and 
endochondral ossification produces bone with little scar tissue and almost indistinguishable 
characteristics from surrounding native bone.
4
 In critically sized defects or where natural 
regeneration is insufficient, clinicians may apply these regenerative techniques to augment bone 
repair. 
Derived from historical practices of tissue engineering and biological scaffolding, cell-based 
regenerative medicine is drawing progressively more attention in recent years based upon its 
great potential.
5
 Human mesenchymal stem cells (MSCs) show great promise in regenerative 
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medicine for their ability to enhance cell proliferation and differentiation, increase angiogenesis, 
and modulate the immune response. Many of the regenerative properties of MSCs have been 
demonstrated to be mediated though cell-derived by-products, known as exosomes.
6
  Exosomes 
are a specific class of lipid-membrane-bound extracellular vesicles, ranging from 40-150nm in 
diameter. They are produced by many cell types, contain various functional proteins, mRNAs, 
microRNAs, and lipids, and play a critical role in cell-to-cell communication.
7
  Bioactive 
molecules are encapsulated in these vesicles and are subsequently transferred to cells in the local 
environment or distant organs, and may regulate the behavior of recipient cells. Exosome-based 
therapies in animal models have been shown to promote the regeneration of tissues in various 
organs, including the heart, kidney, skin, and nervous system by participating in important 
pathways of development, organogenesis, wound healing, and regeneration.
8–11
 Their 
regenerative potential may also be modulated by the exposure of the originating cell population 
to external stimuli, such as hypoxia.
12
 
Treatment with exosomes has some advantages over delivery of human cells, including 
resistance to degradation, superior stability and durability, ease of storage, and lower potential 
for immune rejection, and therefore may represent a generally non-cytotoxic and well-tolerated 
regenerative therapy.
6
 The specific aim of this study is to determine if the delivery of exosomes 
into rat calvarial defects will increase regeneration by reducing the residual defect area and 
enhancing bone volume. This in vivo model consisted of creating 5mm bilateral calvarial defects 
in male Sprague-Dawley rats, delivering high-dose or low-dose exosomes in collagen gel, or a 
control gel without exosomes into the defects, and examining the defects after four weeks to 






N = 24 defects 
(12 rats) 
Treatment Group 
High Dose Exosome 
(10 µg)  
N = 8 defects  
(4 rats) 
Low Dose Exosome 
(2 µg)  
N = 8 defects 
(4 rats) 
No Treatment Group 
(Control) 
Collagen soaked in 
PBS 
N = 8 defects 
(4 rats) 
 
Figure 1: Experimental Design. Flow chart depicting the division of 12 male Sprague-Dawley 




Human bone marrow stromal cells were cultured with exosome-depleted media for 48 
hours. The media were collected and exosomes were harvested by sequential ultracentrifugation 
with the following protocol: cell debris and large cell fragments were removed first at a 
gravitational force of 500g for 10 minutes; then at 2,000g for 10 minutes; and finally at 10,000g 
for 30 minutes. Exosomes were then collected at 100,000g for 70 minutes and the pellets were 
washed in 0.9% NaCl and centrifuged a second time at 100,000g for 70 minutes. The pellets 
were then re-suspended in phosphate-buffered saline (PBS) and stored at -80
0
C for the animal 
experiment.  
All procedures performed on animals followed protocols approved by the Institutional 
Animal Care and Use Committee (IACUC) at Virginia Commonwealth University (Protocol 
#AD10001541). Twelve male Sprague-Dawley rats (approximately 250 to 300 grams, aged 9 to 
10 weeks) were divided into three groups: no treatment (collagen soaked in PBS), high-dose 
exosome (collagen soaked in 10 µg exosomes), and low-dose exosome (collagen soaked in 2 µg 
exosomes) (Figure 1). The rats were anesthetized with 4% isoflurane in O2 for induction and 
then maintained at 1-3% isoflurane in O2. A subcutaneous injection of buprenorphine 
(1.0mg/kg) was used for perioperative analgesia, after which the surgical site was shaved and 
cleaned with betadine and 70% ethanol. Once the rats were transferred to the heated surgical 
table and covered with sterile drapes, a linear scalp incision was made from the nasal bone to the 
occiput, and full-thickness flaps were elevated. The periosteum overlying the calvarial bone was 
completely reflected. 
Trephine burs under copious irrigation were used to create bilateral 5mm craniotomy 
defects in each rat, centered on each side of the parietal calvarial bone (Figures 2 and 3). 
5 
 
Attention was given to avoid damaging the sagittal suture. The calvarial disks were carefully 
removed to prevent injury to the underlying dura or brain. The three groups were randomized 
and defects were implanted with either high-dose (10 µg) or low-dose (2 µg) exosome 
concentrates in a collagen gel, or a PBS soaked collagen matrix without exosomes to serve as the 
control. The periosteum was sutured internally with interrupted sutures using 4-0 chromic gut, 
and the incisions were closed with continuous interlocking sutures using 4-0 chromic gut sutures. 
The closed surgical sites were cleaned again with betadine, and the rats were recovered from 
anesthesia on a heating pad. One rat died during surgery from anesthetic complications; however 
the remaining 11 rats convalesced with no post-operative complications. All rats were sacrificed 
with carbon dioxide inhalation four weeks after implantation, and the calvaria were harvested 
and fixed in 10% formalin. 
Calvarial bone regeneration was quantified by the use of a Bruker Skyscan 1173 Micro-
CT (Billerica, MA). The harvested calvaria were scanned and raw images were generated. The 
images were examined at thresholds ranging from 110-190 Hounsfield units (Hu) to further 
exclude immature bone. A region of interest was generated using a cylindrical section with a 
5mm radius to encompass the defect area exclusively. The quantification of new bone was 
established through surface area regrowth percentage and total bone volume in mm
3
 at a 
threshold of 110 Hu.   
The two-dimensional data depicting surface area distribution was analyzed using Fisher’s 
Exact test to evaluate differences in bone fill between treatment and control groups. Next, the 
total bone volume in mm
3 
was analyzed using one-way analysis of variance (ANOVA), followed 
by Bonferroni's multiple-comparison test. P<0.05 was considered to be statistical significance. 
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The results were expressed as means ± standard deviation, and graphs were prepared using 
Graph Pad Prism 7.02 (Graph Pad Software, CA, USA).   
Figure 2: Surgical Design. Rats received one of three possible configurations in both defects. The 
no treatment group was treated with a PBS-soaked collagen gel vehicle to serve as control. The high -
dose exosome treatment group was treated with high-dose (10 µg) MSC exosome via collagen gel 
matrix and the low-dose exosome treatment group was treated with low-dose (2 µg) MSC exosome 
via collagen gel matrix. 
Figure 3: Surgical Photos. a) Pre-operative photo: shaved rat calvaria with sterile drape in place 
after betadine disinfection. b) Intra-operative photo: split-thickness dissection to access calvaria and 
2x 5mm defects surgically created with trephine bur to remove thin disc of calvarial bone while 
leaving underlying dura matter intact. c) Post-operative photo: primary closure with continuous 




The first parameter measured in this study was the area of defect recovery following 
different treatment modalities. The results demonstrated a relatively large variance in the area of 
the defect covered by new bone (Figure 4). Surprisingly, most of the defects resulted in more 
than 50% recovery. However, when further stratifying the healing into three different categories 
(<80% recovery, 80-90% recovery, and >90% recovery), collagen soaked in high-dose exosomes 
led to better bone healing, as evidenced by the finding that 4 out of the 8 defects exhibited 
greater than 90% recovered surface area. In contrast, this observation was rare in the low-dose 
exosome group (1 in 6 defects), and in the PBS-soaked collagen control group (0 in 8 defects) 
(Figure 5). Stratifying the bone fill into three levels failed to achieve statistical significance 
between the three groups (p=0.23). When bone fill was dichotomized into >90% and ≤90%, 
however, significance was reached (p=0.04), further demonstrating better bone healing in the 
high-dose exosome group (Figure 6). 
Next, bone volume (mm
3
) was measured within the defect area. At the threshold of 110 
Hu (a standard threshold for bone), it was observed that treatment with the high-dose exosome 
appears to have higher bone volume than the other groups, although no statistical difference was 
seen due to the small sample size (p= 0.48) (Figure 7). When a variety of thresholds were applied 
to differentiate the maturity of the newly-formed bone, this trend was more prominent as the 
threshold increased, suggesting that more mature bone was found in the high-dose exosome 
group. Conversely, the low-dose exosome group did not appear to be much different from the 
collagen gel control. In addition, there was a larger variance in the high-dose exosome group 




















 Figure 4: 2D Surface Area Analysis. Surface area analysis comparing the collagen gel control, 
high-dose exosome, and low-dose exosome groups at a threshold of 180 Hu. The 5mm defect is 
represented by the circle above, with the bone fill being depicted in yellow and absence of bone 
(likely soft tissue in-growth) is depicted in red. 
Figure 5: Surface Area Distribution. Bar graphs depicting three parameters of the recovered 
surface area of bone per number of defects for collagen control, high-dose exosome (10 µg), and 




Figure 7: Surface Area Distribution. Bar graphs depicting three parameters of the recovered 
surface area of bone per number of defects for collagen control, high-dose exosome (10 µg), and 
low-dose exosome (2 µg) groups 
Figure 6: Volumetric Measurements at Varying Thresholds.  Scatter plots showing bone 
volume in mm
3
 at thresholds 110, 130, 150, and 170 for collagen control, high-dose exosome 




Bone grafting with autogenous and non-autogenous grafts remains the standard of care in 
human bone regeneration, but limitations persist, particularly in the recovery time and associated 
morbidity of the procedure. Human mesenchymal stem cells show great potential in regeneration 
due to their ability to enhance cell proliferation and differentiation, increase angiogenesis, and 
modulate the immune response. In this study, more defects treated with high-dose (10 µg) MSC 
exosomes achieved greater than 90% surface recovery as compared to the low-dose (2 µg) and 
control groups. As assessed using 3-D measurement, greater bone volume overall was seen in the 
high-dose exosome group, although this was not statistically significant (p=0.48). When the 
thresholds for bone tissue were adjusted, the differences between the high-dose group and 
control group appeared to be greater, suggesting that exosome treatment may be associated with 
more mature bone formation. The four-week time period of this study, however, may have been 
too short. At four weeks, most of the regenerated bone may have consisted of woven, or 
immature, bone.
13,14
 This is based on the knowledge that it takes approximately 38 days to for a 
human extraction socket to become 2/3 filled with trabecular bone, and human intra-bony defects 
can take anywhere from 2-3 months to heal completely, based on histologic evidence.
15
 Thus, 
longer time points may help us better understand the potential effects of exosomes on the 
maturation bony defects.  
Many defect healing studies use bone volume recovery as a benchmark for healing, 
however volume recovery measurements alone do not adequately explain the nature of the bone 
healing that occurs in this model. The geographic pattern of new bone formation in these defects 
is another important consideration that may contribute to understanding bone healing. In critical 
size defect models, center healing is typically considered the most difficult to achieve and may 
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be a valuable benchmark for measuring defect healing with full-width viewing. In this study, 
data from a side by side comparison of the high-dose and low-dose exosome groups versus the 
collagen control group indicated that more defects treated with exosomes exhibited coverage at 
the center of the circular defects than those in the collagen group (Figure 4). In a separate but 
similar study, the 5mm circular calvarial defect was treated with high-dose exosomes or a 
collagen gel control. A more in-depth micro-CT examination of the defects was performed. In 
this case, the 5mm defects were examined at sequentially smaller disc-shaped zones of 4, 3, 2, 
and 1mm diameters that originated from the defect center to investigate bone regeneration 
patterns.
16
 This division was done with the knowledge that the defect center, which is the furthest 
point away from the scaffold of native bone, is typically the most challenging area to treat. When 
the defect area was separated into these smaller zones, a pattern of enhanced bone healing 
appeared towards the center of the defect, and greater regeneration was observed in the exosome 
groups as compared to the collagen groups, with this difference becoming greater with increased 
proximity to the defect center. Those findings were consistent with what was observed in this 
study.  
Several studies have been published that document the benefits of exosomes and the 
potential applications of exosome therapy in dentistry. A study by Chew et al in 2019 examined 
the effects of human MSC exosome-loaded collagen sponge on periodontal regeneration of 
surgically created intrabony defects in an immunocompetent rat model.
17
 The defects treated 
with collagen sponges loaded with exosomes showed a reduction in the size of the bone defect in 
comparison to the collagen sponge alone and untreated groups. Exosome-treated rats had more 
effective repair of the defects with regeneration of newly formed bone and periodontal ligament. 
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It was concluded that exosomes enhanced regeneration through increased cellular migration, 
proliferation, synthesis, and differentiation into new bone and PDL.  
Qi et al measured the effect of critical size calvarial defects in Sprague-Dawley rats 
treated with β-TCP loaded with high-dose or low-dose exosomes as compared to β-TCP alone.7 
Similar to the trend observed in this study, the β-TCP group treated with high-dose exosome 
exhibited more newly formed bone and higher bone density. Additionally, both the high-dose 
and low-dose exosome β-TCP groups showed increased neo-angiogenesis as compared to β-TCP 
treatment alone. In another study, Liang et al examined the effects of pretreating stem cells with 
Dimethyloxaloylglycine (DMOG), a molecule that inhibits the ability of prolyl hydroxylase to 
regulate the stability of HIF-1α, thereby mimicking hypoxia in cells under normal oxygen 
levels.
18
 Based on the knowledge that exposure to oxidative stress induces the expression of 
proangiogenic proteins, that study examined the effects of treatment with DMOG on increased 
angiogenesis and bone regeneration in a critical size calvarial defect rat model. The results of the 
study demonstrated  more newly formed bone in the DMOG treated exosome group, markedly 
higher new bone volume relative to tissue volume, and greater neovascularization. In summary, 
the addition of DMOG to MSC exosomes is a promising pretreatment for exosome-based 
approaches to treating bone defects. 
Mohammed studied the effects of using exosomes as an adjunct to nonsurgical 
periodontal therapy versus scaling and root planing alone in a rat ligature model.
19
 The authors 
found that the exosome group exhibited the least amount of inflammatory infiltrate and 
demonstrated signs of new periodontal tissue formation at two days. At two weeks, the exosome 
group showed the greatest degree of proliferation in periodontal tissues with increased cellularity 
and organization, and at four weeks the exosome group showed the most significant signs of 
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healing. Based on these results, adjunctive exosome treatment is a promising regenerative 
technique to enhance therapeutic outcomes of nonsurgical periodontal therapy. 
The results of the current study are in line with aforementioned observations. The 
primary aim of this pilot study was to determine the appropriate dose of exosomes in future 
calvarial defect model studies. Power analysis was conducted based on preliminary results and if 
the volume of newly-formed bone is used as the primary outcome, achieving a level of statistical 
significance in future studies would require a sample size of 11 per group to achieve a type I 
error rate of less than 5%, given the same defect size and with sufficient power (80%). Similarly, 
because there was not a large difference between the low-dose exosome group and the collagen 
control group, future studies may be conducted to compare only two groups, the high-dose 
exosome group and the collagen group while also incorporating a negative or empty control. 
Another possibility for future studies would be to use Sprague-Dawley rats that are older. In this 
study the rats were between 9 and 10 weeks old, at which point they exhibit a very strong natural 
growth ability and regenerative potential. This may imply that older rats be used in future studies 
to minimize the effects of the strong natural regenerative potential observed in younger rats. 
Finally, one may question whether the defects created in this study were truly critical size 
defects. By definition, a critical size defect is one that will not fully regenerate in the natural 
lifetime of the animal.
20
 While some studies propose that the 5mm defect is critically sized, 
others advocate for an 8mm critical defect in rat calvaria.
21
 In this study, the natural regenerative 
potential in the collagen control groups after only four weeks of healing indicates that the defect 




Defects treated with high-dose MSC exosomes demonstrated a trend towards enhanced 
healing, structural integrity, and growth uniformity in a calvarial defect model. Based on the 
results of this pilot study, treatment with MSC exosomes could be a promising therapeutic 
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